AlphAIalphai — Financial news for AI agents
MarketBeatMAR 172 min read$MBOT

Microbot Medical (MBOT) to Release Earnings on Tuesday

Microbot Medical (NASDAQ:MBOT) is scheduled to release its earnings report before market open on Tuesday, March 24th, with analysts projecting an EPS of ($0.06) and revenue of $0.113 million. The stock currently has a "Moderate Buy" rating with an average target price of $7.50, and institutional investors have recently adjusted their stakes in the company. MBOT opened at $2.73, with a market cap of $183.35 million.

Original reporting
MarketBeat · MarketBeat
Published Mar 17, 2026, 6:14 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 17, 2026, 7:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Microbot Medical (MBOT) to Release Earnings on Tuesday — source image
Source · MarketBeat
Decision brief

The 30-second read

$MBOTNeutralMed
01

Why it matters

Earnings release is a key event; market reaction will depend on actual results versus expectations.

02

Market read

The upcoming earnings report is a significant event for MBOT, with moderate analyst optimism but limited broader market impact.

03

What to watch

Potential positive surprise from new product developments or strategic partnerships announced alongside earnings.

Timing: High, as earnings are scheduled for March 24, 2026.

Background

Microbot Medical is a NASDAQ-listed medical device company with a focus on minimally invasive robotic solutions.

Company-level read

Ticker impact

$MBOTNeutralMedium confidence
Context

The upcoming earnings report is a key event for Microbot Medical, with moderate analyst optimism.

Expected impact

Potential short-term increase if earnings beat expectations; risk of decline if results are below forecasts.

Evidence & confidence

Earnings are scheduled soon, and analyst projections are modest. Market reaction will depend on actual results relative to expectations, but the low relevance score indicates limited immediate impact beyond short-term volatility.

Market effects

Sector

Limited sector impact; Microbot operates in the medical device sector, which may see slight volatility.

Regional

Minimal regional effects; company is US-based and news is company-specific.

Global

Negligible; the event is unlikely to influence global markets.

Counterpoint

What could challenge this read

Earnings may disappoint, leading to a decline in stock price, especially if revenue or EPS fall short of projections.

Key entities

  • Company
    Microbot Medical

    A medical device company specializing in robotic minimally invasive solutions.

Read at source← All news

Related articles

JUL 7
$MBOTMed

Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026

Microbot Medical (Nasdaq: MBOT) reported Q2 2026 revenue and new-customer growth of more than 100% vs Q1 2026, citing the LIBERTY System’s full market release on April 13. The company says procedure volumes rose at prior limited-release sites, expanded U.S. sales territories from 4 to 8 (target 12 by year-end), added a federal-services agreement, and received Israeli marketing clearance.

manilatimes.net3 min
AUG 8
$SUNEMedAI 8/10

Pentagon to invest $400m in Australian rare earth mine

Sunrise Energy Metals said the US Pentagon will provide a conditional $400 million loan commitment to develop Syerston, a proposed scandium mine in Fifield, NSW. The project targets Western supply of scandium used in defence and other sectors amid China’s export restrictions. Sunrise also said it has a deal with Lockheed Martin for 25% of output for five years.

bssnews.net4 min
AUG 8
$WTRGMed

Trump administration to invest $3 billion in minerals projects to boost US defence supply chains

President Trump said the US will invest $3 billion in critical minerals and battery projects to expand domestic supply chains for national security. He announced Defence Department Office of Strategic Capital conditional loans totaling $1.4B to Sila Nanotechnologies, $400M to Sunrise Energy Metals, and $150M to Niron Magnetics, plus $58M Export-Import Bank loans. The plan also includes $100M in mining-school grants and $80M for three schools.

tribune.com.pk6 min
AUG 8
$NVDAMed

Nvidia to Invest Up to $3 Billion in Blackstone

The Information reported Nvidia plans to invest up to $3 billion in Lancium, a Blackstone-backed power and data center infrastructure developer tied to the Stargate AI initiative. Nvidia would initially put in $2 billion for a 20% stake, with up to $1 billion more contingent on performance thresholds. No company comment was provided.

econotimes.com4 min
AUG 8
$NVDAMed

Nvidia to invest up to US$3 billion in Stargate data centre developer Lancium: The Information

Nvidia plans to invest up to $3 billion in Lancium, the developer of the Stargate data center campus in Texas, The Information reported. Nvidia would invest $2 billion for about a 20% stake, with an additional $1 billion possible based on grid hookup thresholds. Lancium’s land and power portfolio has an enterprise value near $10 billion, and it may explore an IPO in 2027.

businesstimes.com.sg4 min
AUG 8
$USARMed

Is USA Rare Earth (USAR) Overvalued On Its DOE Funding And Tokenization Buzz?

Simply Wall St says USA Rare Earth (USAR) shares have rebounded after being selected by the U.S. Department of Energy for up to $19.3M in federal funding, pending final negotiations, for a pilot-scale rare earth separations project. The article cites mixed valuation views, with a “fair value” of $0.33 versus a DCF estimate of $83.09, and notes recent price returns.

simplywall.st6 min